Anpac Bio-Medical Science Co. sell Lokrim
Start price
19.08.23
/
20%
€1.97
Target price
19.08.24
-
Performance (%)
-77.46%
End price
19.01.24
€0.44
Summary
This prediction ended on 19.01.24 with a price of €0.44. Lokrim correctly predicted massive losses of -77.46% for Anpac Bio-Medical Science Co.. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Anpac Bio-Medical Science Co. | - | - | - |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
According to Lokrim what are the pros and cons of Anpac Bio-Medical Science Co. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Lokrim for this prediction
In the thread AnPac Bio-Medical Science Co. Ltd. ADR diskutieren
Sell Anpac Bio-Medical Science Co.